Statistics
Publications
50
Citations
11.8K
H-Index
37
Active since
1994
Ingrid Gause‐Nilsson is an author at AstraZeneca (Sweden) specializing in medicine, pharmacology, and diabetes mellitus.
Publications per year
1994–2023
50
50
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca et al. · New England Journal of Medicine · 2018 · 6.3K citations · Full text
Ofri Mosenzon, Stephen D. Wiviott, Avivit Cahn et al. · The Lancet Diabetes & Endocrinology · 2019 · 675 citations · Full text
Medicine, Nephrology, Pharmacology +14
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus
Eri Kato, Michael G. Silverman, Ofri Mosenzon et al. · Circulation · 2019 · 563 citations
Medicine, Cardiology, Pharmacology +15
Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus
Thomas A. Zelniker, Marc P. Bonaca, Remo H.M. Furtado et al. · Circulation · 2020 · 452 citations · Full text
Medicine, Cardiology, Pharmacology +17
1–5 of 50